Overall Status

Completed (8)

Active, not recruiting (2)

Not yet recruiting (2)

Recruiting (2)

Phase

n/a (3)

phase 2 (2)

phase 3 (2)

phase 2/phase 3 (1)

phase 4 (1)

Collaborator

National Cancer Institute (NCI) (1)

National Polytechnic Institute, Mexico (1)

The Novartis Foundation (1)

Universidad Nacional Autonoma de Mexico (1)

Vanderbilt University Medical Center (1)

Study Documents

Intervention Type

drug (8)

diagnostic test (2)

other (2)

procedure (2)

device (1)

Funder Type

Other (10)

Industry (4)

Study Type

Interventional (9)

Observational (5)

hyperparathyroidism, primary

Showing 1 - 14 of 14

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

18F-fluorocholine, Positron-Emission Tomography, Hyperparathyroidism, Primary Trial in Toronto ([F-18]-FCH PET/MRI)

Active, not recruiting

18F-fluorocholine
+2 more

[F-18]-FCH PET/MRI

Toronto, Ont, Canada

UHN

Dec 9, 2022

The Bone-parathyroid Crosstalk in Primary Hyperparathyroidism

Not yet recruiting

Hyperparathyroidism, Primary
+2 more

Biomarker assays

Milan, Italy

IRCCS Istituto Ortopedico Galeazzi

Sep 28, 2022

Parathyroid Diseases, Parathyroid Dysfunction, Parathyroid Tumors Trial in San Francisco (Parathyroid Eye (PTeye))

Active, not recruiting

Parathyroid Diseases
+9 more

Parathyroid Eye (PTeye)

San Francisco, California

University of California, San Francisco

Jul 27, 2022

Postmenopausal Osteoporosis, Postmenopause, Hyperparathyroidism, Secondary Trial in Mexico City (Cholecalciferol)

Completed

Postmenopausal Osteoporosis
+4 more

Cholecalciferol

Mexico City, Mexico

Peri-postmenopause and bone metabolism clinic. Regional Hospital

Apr 30, 2022

Primary Hyperparathyroidism and Gut Microbiota

Recruiting

Hyperparathyroidism, Primary

there will be no intervention, this is an observational study

Lausanne, Switzerland

Patrizia D'amelio

Feb 28, 2022